The Journal of Immunology, Vol 142, Issue 1 1-7, Copyright © 1989 by American Association of Immunologists

ARTICLES

T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression

P Benaroch and G Bordenave
Unite d'Immunophysiologie Moleculaire, Institut Pasteur, Paris, France.

We established the phenotype of T splenocytes (Ts) from Igha/a BALB/c mice sensitized against B splenocytes from the Ighb/b CB20 congenic mice that induce Igh-1b (IgG2a of the Ighb haplotype) suppression. This was achieved by studying the action of anti-T cell subset mAb on the capacity of Ts to induce this chronic allotypic suppression in Igha/b (BALB/c x CB20)F1 mice. The Ts were treated with cytotoxic anti-mouse CD4 or anti-mouse CD8 rat mAb in vitro before their injection into the Igha/b newborns or in vivo after their injection into the Igha/b newborns. Exposure to either anti-CD8 or anti-CD4 mAb in vitro or in vivo leads to loss of the capacity of Ts to induce Igh-1b allotypic suppression. Mixing CD4+-cell-depleted Ts and CD8+-cell-depleted Ts preparations restored the capacity of the cells to induce Igh-1b suppression. Thus, both CD4+ CD8- Ts and CD4- CD8+ Ts are required for the induction of this allotypic suppression. Bone marrow cells and B splenocytes from Igh-1b-suppressed adult Igha/b mice were shown to be able to durably express Igh-1b when transferred into irradiated Igha/a BALB/c hosts whereas whole spleen cells from such donors failed to do it. Abrogation of Igh-1b suppression by in vivo anti-CD8 mAb treatment was achieved in adult Igha/b heterozygotes but with a lower efficiency than in adult Ighb/b homozygotes, all being chronically Igh-1b suppressed. The CD4- CD8+ cell population essential for maintaining this suppression is resistant to in vivo 600 rad irradiation and seems to be slightly inhibited by in vivo administration of free Igh-1b.

This article has been cited by other articles:

				C. M. Snyder, K. Aviszus, R. A. Heiser, D. R. Tonkin, A. M. Guth, and L. J. Wysocki Activation and Tolerance in CD4+ T Cells Reactive to an Immunoglobulin Variable Region J. Exp. Med., November 8, 2004; (2004) jem.20031234. [Abstract] [Full Text] [PDF]

				L. Majlessi and G. Bordenave Role of CD40 in a T Cell-Mediated Negative Regulation of Ig Production J. Immunol., January 15, 2001; 166(2): 841 - 847. [Abstract] [Full Text] [PDF]

				L. Majlessi and G. Bordenave Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2ab-producing B cells Int. Immunol., July 1, 2000; 12(7): 969 - 976. [Abstract] [Full Text] [PDF]

				L. Majlessi and G. Bordenave Evidence of Alternative or Concomitant Use of Perforin- and Fas-Dependent Pathways in a T Cell-Mediated Negative Regulation of Ig Production J. Immunol., April 15, 1999; 162(8): 4391 - 4398. [Abstract] [Full Text] [PDF]

				W. M. Clark and J. A. Zivin Antileukocyte adhesion therapy: preclinical trials and combination therapy Neurology, November 1, 1997; 49(5_Suppl_4): S32 - S38. [Full Text] [PDF]

				S. Schnittman, M. Psallidopoulos, H. Lane, L Thompson, M Baseler, F Massari, C. Fox, N. Salzman, and A. Fauci The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4 Science, July 21, 1989; 245(4915): 305 - 308. [Abstract] [PDF]